Finance

Beta
Lists
BCLI:OTCMKTS
Brainstorm Cell Therapeutics Inc
$0.75
-5.61%
(-0.044) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BCLI...
Open
$0.79
High
$0.83
Low
$0.72
Mkt. cap
8.29M
Avg. vol.
11.08K
Volume
28.10K
52-wk high
$1.33
52-wk low
$0.46
EPS
-$0.94
Beta
0.30
Shares outstanding
11.04M
No. of employees
20
Open
$0.79
High
$0.83
Low
$0.72
Mkt. cap
8.29M
Avg. vol.
11.08K
Volume
28.10K
52-wk high
$1.33
52-wk low
$0.46
EPS
-$0.94
Beta
0.30
Shares outstanding
11.04M
No. of employees
20
News stories
From sources across the web
About Brainstorm Cell Therapeutics Inc
CEOChaim Lebovits | Stacy R. Lindborg
Employees20
Founded2000
Headquarters-
SectorBiotechnology
Websitebrainstorm-cell.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.30M
1.12M
899.00K
852.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.78M
1.45M
1.15M
1.39M
Operating expense
3.09M
2.57M
2.05M
2.24M
Total operating expenses
3.09M
2.57M
2.05M
2.24M
Operating income
-3.09M
-2.57M
-2.05M
-2.24M
Other non operating income
179.00K
-
-
-
EBT including unusual items
-2.86M
-2.90M
-2.11M
-2.43M
EBT excluding unusual items
-2.86M
-2.90M
-2.11M
-2.43M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.86M
-2.90M
-2.11M
-2.43M
Net profit margin
-
-
-
-
Earnings per share
-0.45
-0.34
-0.19
-0.13
Interest and investment income
46.00K
-
-
-
Interest expense
-
-330.00K
-59.00K
-190.00K
Net interest expenses
46.00K
-330.00K
-59.00K
-190.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.04M
-2.52M
-2.00M
-2.20M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer